Zdrowie i gospodarka · 21/06/2005

FDA to Host Public Workshop on Leukocyte Reduction in Blood and Blood Components

The US Food and Drug Administration (FDA) will host a public workshop to discuss updates on leukocyte reduction in blood and blood components, a process used to remove white blood cells from donated blood products.